Viewpoint Molecular Targeting has been selected by the National Cancer Institute (NCI) to participate in the business accelerator program I-Corps in 2017.

Viewpoint Molecular Targeting, LLC founders met with Iowa legislators at the National Council on Entrepreneurial Tech Transfer (NCET2) National Demo Day. The purpose was to educate them on the key role university based biomedical startups play in creating high value jobs and in improving national economic and social competitiveness.

Viewpoint Molecular Targeting recently received an invitation to present at the National Council of Entrepreneurial Tech Transfer (NCET2) University Startups Demo Day on Sept. 20 in Washington, D.C. Founded with the support of UI Ventures and housed in the University of Iowa Research Park's BioVentures Center, Viewpoint Molecular Targeting was one of 35 companies representing universities around...

Pharmaceutical startup company Viewpoint Molecular Targeting, LLC, has received its fourth consecutive collaborative Small Business Innovation Research (SBIR) Grant, awarded by the National Institutes of Health, for $300,000.